COVID-19 Pivot: Industry’s Response on International Clinical Trials Day

Happy International Clinical Trials Day subscribers! To mark this important day, we gathered some leaders from the Australian MTP sector to discuss the power and importance of clinical trials in the discovery of new medicines and treatments for patients, a COVID-19 vaccine trial starting soon in Australia, and how important the clinical trials sector will be in contributing to Australia’s post-COVID recovery. Hear from Dr Paul Griffin, A/Prof of Medicine at the University of Queensland’s Faculty of Medicine, Director of Infectious Diseases at Mater Health Services & Medical Director and principal investigator at Nucleus Network/Qpharm, Carrie Bloomfield, Co-Chair of the Industry-supported R&D Taskforce & Head of Clinical Operations at GlaxoSmithKline and MTPConnect’s Managing Director & CEO Dr Dan Grant, Senior Director Stakeholder Engagement Dr Rebecca Tunstall & Director of Communications & Events Caroline Duell.